Lungs News and Research

RSS

American Lung Association's report examines lung cancer among African Americans

The American Lung Association today released its report, Too Many Cases, Too Many Deaths: Lung Cancer in African Americans, a compilation of research examining lung cancer among African Americans and the need to eliminate this and other health disparities.

13 Apr 2010

Drug boosting production of immune system protein worsens TB

An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health. The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.

13 Apr 2010

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

Today, Lung Cancer Alliance announced new additions to the growing list of supporters joining LCA in its "call to action" to devise a better public health strategy to address the nation's most lethal cancer.

13 Apr 2010

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Aeolus Pharmaceuticals, Inc. announced today that a second study of its lead drug, AEOL 10150, has been initiated by the National Institutes of Health's (NIH), National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear Medical Countermeasures development program as a countermeasure for radiation exposure to the gastrointestinal (GI) tract.

13 Apr 2010

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists at The University of Texas Health Science Center at Houston (UTHealth) were awarded stimulus grants totaling almost $2 million to research experimental treatments for blood disorders and inherited lung diseases affecting children.

13 Apr 2010

Hunter Valley cancer cluster report to be made public

Cancer cases may have manifested as brain tumors in the local population in Upper Hunter Valley as a result of pollution from mines and power stations. With five residents in a single block in Singleton being diagnosed with brain tumors a public inquiry to establish just how harmful dust and toxins from the mines and power stations are had been constituted by the state government.

13 Apr 2010

Obese children have stiffer arteries than leaner counterparts

Children with more body fat and less endurance than their fitter, leaner counterparts have stiffer arteries at a young age, Medical College of Georgia researchers said.

12 Apr 2010

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

In a competition modeled after TV quiz shows, a team of neurologists from the United States will face Canadian neurologists in the annual "Neurobowl®" on April 11.

12 Apr 2010

Asthma-like symptoms in infants and toddlers is often RAD

Your child is wheezing. Your child must have asthma, right? Not always, says Julie Koehler, professor and chair of the Department of Pharmacy Practice in Butler University's College of Pharmacy and Health Sciences and clinical pharmacy specialist in family medicine at Clarian Health.

12 Apr 2010

Three nonprofit organizations launch campaign to increase national awareness of PF

The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.

12 Apr 2010

Nationwide Asthma Screening Program to find people at risk

The American College of Allergy, Asthma and Immunology will help adults and children to find out if they are at risk for asthma through its Nationwide Asthma Screening Program. More than 200 screenings will take place across the country this year. Locate one near you on the calendar of screenings available at AllergyAndAsthmaRelief.org.

12 Apr 2010

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots.

9 Apr 2010

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.

9 Apr 2010

WTC FDNY Rescue Workers have not recovered normal lung function, yet

A study of nearly 13,000 rescue workers from the Fire Department of the City of New York (FDNY) shows that the significant proportion who suffered acute lung damage after exposure to World Trade Center (WTC) dust have not recovered normal lung function in the years since the September 11, 2001 terrorist attacks.

8 Apr 2010

OncoGenex Pharmaceuticals recognized with BIOTECanada's Gold Leaf Award

OncoGenex Pharmaceuticals, Inc. announced today that the Company will be presented with BIOTECanada's Gold Leaf Award as biotech company of the year. The award recognizes a biotech company that has distinguished itself from its peers with strong overall performance as a company, demonstrated leadership and shown significant achievement.

8 Apr 2010

Reliable immune monitoring tool for assessment of cancer vaccine-induced CD4+ T-cell response

A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.

8 Apr 2010

Role of beta defensins in development of chronic inflammatory response in the brain

Researchers at the Case Western Reserve University School of Dental Medicine and School of Medicine will look for evidence within the brain for human beta defensin peptide function-proteins important to the peripheral body's natural defense system against infection from the outside environment.

8 Apr 2010

Obstructive sleep apnea more than doubles stroke risk in men

Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.

8 Apr 2010

9/11 rescue teams’ lungs still affected and aged by 12 years: say researchers

In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.

8 Apr 2010

First proton therapy center for New Jersey

Cancer survivors joined representatives from ProCure Treatment Centers, Inc., Princeton Radiation Oncology, and CentraState Healthcare System to break ground on the ProCure Proton Therapy Center in Somerset - the first proton therapy center to be built in the state, located 40 miles from downtown Manhattan.

8 Apr 2010

Lungs News and Research

American Lung Association's report examines lung cancer among African Americans

Drug boosting production of immune system protein worsens TB

National organizations, medical institutions join Lung Cancer Alliance to address nation's most lethal cancer

NIAID funds second study of Aeolus Pharmaceuticals' AEOL 10150 as potential countermeasure to GI-ARS

Stem cell scientists receive stimulus grants to study lung and blood disorders

Hunter Valley cancer cluster report to be made public

Obese children have stiffer arteries than leaner counterparts

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Asthma-like symptoms in infants and toddlers is often RAD

Three nonprofit organizations launch campaign to increase national awareness of PF

Nationwide Asthma Screening Program to find people at risk

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

WTC FDNY Rescue Workers have not recovered normal lung function, yet

OncoGenex Pharmaceuticals recognized with BIOTECanada's Gold Leaf Award

Reliable immune monitoring tool for assessment of cancer vaccine-induced CD4+ T-cell response

Role of beta defensins in development of chronic inflammatory response in the brain

Obstructive sleep apnea more than doubles stroke risk in men

9/11 rescue teams’ lungs still affected and aged by 12 years: say researchers

First proton therapy center for New Jersey

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News